These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model. Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693 [TBL] [Abstract][Full Text] [Related]
4. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients. Blanco AN; Peirano AA; Grosso SH; Gennari LC; Bianco RP; Lazzari MA Haematologica; 2000 Oct; 85(10):1045-50. PubMed ID: 11025595 [TBL] [Abstract][Full Text] [Related]
5. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy. Scandella D; Reyes H; Felch M; Sakurai Y Haematologica; 2000 Oct; 85(10 Suppl):86-8. PubMed ID: 11187882 [TBL] [Abstract][Full Text] [Related]
6. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors. Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406 [TBL] [Abstract][Full Text] [Related]
7. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains. Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535 [TBL] [Abstract][Full Text] [Related]
8. Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies. Calvez T; Laurian Y; Goudemand J J Thromb Haemost; 2008 Feb; 6(2):390-2. PubMed ID: 18036187 [No Abstract] [Full Text] [Related]
9. [Detection of alloantibodies against Factor VIII in plasma of patients with hemophilia A and its relationship with Factor VIIIC domain]. Zhang LL; Yu ZQ; Wan CC; Zhang W; Zhang ZH; Ruan CG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1211-4. PubMed ID: 24156436 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous detection and epitope mapping of anti-factor VIII antibodies. Lavigne-Lissalde G; Tarrade C; Lapalud P; Chtourou S; Schved JF; Granier C; Villard-Saussine S Thromb Haemost; 2008 Jun; 99(6):1090-6. PubMed ID: 18521513 [TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of factor VIII inhibitor antibodies of Chinese origin. Huang CC; Shen MC; Chen JY; Hung MH; Hsu TC; Lin SW Br J Haematol; 2001 Jun; 113(4):915-24. PubMed ID: 11442484 [TBL] [Abstract][Full Text] [Related]
13. Anti-factor VIII antibodies: a 2005 update. Lavigne-Lissalde G; Schved JF; Granier C; Villard S Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627 [TBL] [Abstract][Full Text] [Related]
14. Are low-density lipoprotein receptor-related protein 1 or non-neutralizing antibodies predictors of FVIII in vivo recovery in haemophilia A patients? Clere AS; Diaz I; Lebreton A; Lavigne-Lissalde G; Schved JF; Biron-Andreani C Haemophilia; 2014 Nov; 20(6):e406-8. PubMed ID: 25311419 [No Abstract] [Full Text] [Related]
15. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains. Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780 [TBL] [Abstract][Full Text] [Related]
16. Development of exogenous FVIII-specific inhibitor in a mild haemophilia patient with Glu272Lys mutation. Yamanouchi J; Hato T; Niiya T; Sato Y; Onishi S; Yasukawa M Haemophilia; 2014 Mar; 20(2):e179-82. PubMed ID: 24533958 [No Abstract] [Full Text] [Related]
17. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A. Madoiwa S; Yamauchi T; Kobayashi E; Hakamata Y; Dokai M; Makino N; Kashiwakura Y; Ishiwata A; Ohmori T; Mimuro J; Sakata Y J Thromb Haemost; 2009 May; 7(5):811-24. PubMed ID: 19220731 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A. Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377 [TBL] [Abstract][Full Text] [Related]